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Since the term ‘proteome’ was 
first introduced in 1994, the field 
of proteomics has rapidly grown. 
Although many scientists have 
tried to apply simultaneous large-
scale analysis of proteins to neph-
rology, progress has been slow, in 
part because of technical limita-
tions, challenges in working with 
serum and urine, and the large 
number of different cells in the 
kidney. However, recent method-
ological developments have ena-
bled the proteomic techniques 
needed to improve our under-
standing of renal physiology and 
pathology, as well as to identify 
candidate biomarkers to improve 
diagnosis and therapy. 
The second volume of Proteom-
ics in Nephrology, published in 
2008, gives us an excellent intro-
duction to this dynamic field and 
an updated summary of recent 
scientific discoveries and clini-
cal trials. This book reviews the 
rapid progress in proteomics in a 
wide range of renal diseases. Like 
the first volume, it was edited 
by Visith Thongboonkerd of the 
Medical Proteomics Unit, Siriraj 
Hospital, Mahidol University in 
Bangkok, Thailand, who is an 
established expert in this field. A 
group of international experts in 
protein-based approaches to dif-
ferent kidney diseases contributed 
to each of the different chapters. 
The current volume is quite 
different from the first, which 
provided more of an overview of 
proteomics and data on different 
kidney cell types and urine. The 
second volume handles different 
renal diseases in separate chap-
ters and is a very practical book. 
Studies of acute kidney injury 
(AKI) are emphasized. There 
are a host of candidate biomark-
ers for AKI, and although many 
are promising, to date, none 
has been validated for clinical 
use. Using biomarkers from the 
urine proteome to monitor drug 
responsiveness in nephrotic syn-
drome and allograft rejection is 
currently challenging; however, 
there is the promise of noninva-
sive detection of early progres-
sion, and of ways to minimize 
drug toxicity. The chapter on 
diabetes provides strong evi-
dence for biomarkers beyond 
microalbuminuria. Particularly 
interesting is the section on 
p h a r m a  c o p r o t e o m i c s  f o r 
diabetes, in which the molecular 
structures of novel drugs are 
designed to fit the newly discov-
ered therapeutic target. Metab-
olomics, a relatively new field 
analyzing metabolites from bio-
logical processes, is discussed 
as having promise for AKI and 
risk stratification of allografts. It 
is nice to see a classic problem, 
the search for uremic toxins, get-
ting a new discovery angle and 
emphasis. 
Unlike many other technique 
books, this book has sufficient 
breadth for the kidney aficionado, 
with a chapter on stones and also 
vasopressin signaling. The data-
base and bioinformatics chapters 
provide a useful perspective on 
the tough cognitive/computa-
tional areas that are keys to this 
field after the clinical samples and 
wet-lab work. Chapters on renal-
cell carcinoma pathogenesis and 
newborn obstructive nephropa-
thy demonstrate the importance 
of learning from areas outside that 
of many adult nephrologists’ usual 
reading. Current efforts toward 
constructing a complete database 
of the proteome for urine and dif-
ferent types of cells in the kidney 
will be essential for understanding 
the pathophysiology of various 
diseases and adopting proteomics 
as a strong diagnostic tool. There 
is a lot of redundancy in the book 
where different proteomic tech-
niques are introduced; however, 
this is actually helpful for the 
non-expert—abundant tables, 
such as the one comparing tech-
niques in the capillary electro-
phoresis chapter, can be referred 
to repeatedly. Unfortunately, the 
book misses the opportunity to 
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discuss biomarkers for chronic 
kidney disease and the promise 
for proteomics here.
The chapters are concise and 
generally well illustrated, help-
ing even the non-investigator to 
enjoy this text despite the intimi-
dating title for clinical nephrolo-
gists. One of the challenges in 
such a rapidly developing field is 
to read a book rather than new 
publications. However, the field 
of proteomics has moved more 
slowly than genomics, and this 
fun-to-read book is currently 
useful and will be for some time 
to come for kidney investigators, 
clinicians, and trainees.
